CAMP CIK: 1736730

Camp4 Therapeutics Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−44.2
FY24:
−45.6
FY25:
−29.6
Change from FY22 to FY25
millions USD
FY22:
−4.03
FY23:
−0.68
FY24:
−0.44
FY25:
−0.24
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
0.30
FY24:
71.7
FY25:
75.9
millions USD
FY22:
–
FY23:
−44.5
FY24:
25.7
FY25:
46.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
−42.6
FY23:
−44.8
FY24:
−46.0
FY25:
−29.8

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data